An open-label randomized-controlled trial of low dose aspirin with an early screening test for pre-eclampsia and growth restriction (TEST): Trial protocol

Contemporary Clinical Trials

Volumn 49, Issue , 2016, Pages 143-148

  Mone, Fionnuala ^a,b   Mulcahy, Cecilia ^b   McParland, Peter ^b   Stanton, Alice ^c   Culliton, Marie ^b   Downey, Paul ^b   McCormack, Dorothy ^b   Tully, Elizabeth ^d   Dicker, Patrick ^d   Breathnach, Fionnuala ^d   Malone, Fergal D ^d   McAuliffe, Fionnuala M ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b NATIONAL MATERNITY HOSPITAL   (Ireland)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d ROTUNDA HOSPITAL   (Ireland)

Author keywords

Aspirin; First trimester; Low risk; Placental disease; Pre eclampsia; Screening

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GESTATIONAL AGE; HUMAN; LOW DRUG DOSE; MEDICATION COMPLIANCE; MULTICENTER STUDY; NUCLEOTIDE SEQUENCE; NULLIPARA; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREECLAMPSIA; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; UTERINE ARTERY; DIAGNOSTIC IMAGING; DOPPLER ULTRASONOGRAPHY; EARLY DIAGNOSIS; INTRAUTERINE GROWTH RETARDATION; MASS SCREENING; PATIENT ATTITUDE; PREGNANCY; RISK ASSESSMENT;

ASPIRIN; EARLY DIAGNOSIS; FEMALE; FETAL GROWTH RETARDATION; HUMANS; MASS SCREENING; MEDICATION ADHERENCE; PATIENT ACCEPTANCE OF HEALTH CARE; PLATELET AGGREGATION INHIBITORS; PRE-ECLAMPSIA; PREGNANCY; RISK ASSESSMENT; ULTRASONOGRAPHY, DOPPLER; UTERINE ARTERY;

EID: 84978204654     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2016.07.003     Document Type: Article

References (24)

1. [1] Ananth, C.V., Smulian, J.C., Vintzileos, A.M., Ischaemic placental disease: maternal versus clinical presentation by gestational age. J. Matern. Fetal Neonatal Med. 23:8 (2010), 887–893 (Pubmed PMID: 19895356).
2. [2] Staff, A.C., Benton, S.J., von Dadelszen, P., Roberts, J.M., Taylor, R.N., Power, R.W., et al. Redefining pre-eclampsia using placenta-derived biomarkers. Hypertension 61:5 (May 2013), 932–942 (Pubmed PMID: 23460278).
3. [3] Brown, M.A., Lindheimer, M.D., deSwiet, M., Van Assche, A., Moutquin, J.M., The classification and diagnosis of hypertensive disorders of pregnancy: statement from the international Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens. Pregnancy. 20:1 (2001), IX–XIV (Pubmed PMID: 12044323).
4. [4] Villa, P.M., Kajantie, E., Raikkonen, K., Pesonen, A.K., Hamalainen, E., Vainio, M., et al. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomized placebo controlled PREDO trial and a meta-analysis of randomised trials. BJOG 120:1 (Jan 2013), 64–74 (Pubmed PMID: 23126307).
5. [5] Duley, L., Henderson-Smart, D.J., Meher, S., King, J.F., Antiplatelet agents for preventing preeclampsia and its complications. Cochrane Database Syst. Rev., 1, 2004, CD004659 (Pubmed PMID: 14974075).
6. [6] Roberge, S., Villa, P., Nicolaides, K., Giguere, Y., Vainio, M., Bakthi, A., et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn. Ther. 31:3 (2012), 141–146 (Pubmed PMID: 22441437).
7. [7] Coomarasamy, A., Honest, H., Papaioannou, S., Gee, H., Khan, K.S., Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet. Gynecol. 101:6 (June 2003), 1319–1332 (Pubmed PMID: 12798543).
8. [8] Yu, C.K., C, A.T., Papageorghiou, M., Parra, R., Dias, P., Nicolaides, K.H., Fetal Medicine Foundation Second Trimester Screening Group. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet. Gynecol. 22:3 (2003), 233–239 Sept. (Pubmed PMID: 12942493).
9. [9] Askie, L.M., Duley, L., Henderson-Smart, D.J., Stewart, L.A., Paris collaborative group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 369:9795 (2007), 1791–1798 May. (Pubmed PMID: 17512048).
10. [10] Kozer, E., Nikfar, S., Costei, A., Boskovic, R., Nulman, I., Koren, G., Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am. J. Obstet. Gynecol. 187:6 (2002), 1623–1630 Dec. (Pubmed PMID: 12501074).
11. [11] [No authors listed]Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. Br. J. Obstet. Gynaecol., 102(11), 1995, 861–868 Nov. (Pubmed PMID: 8534620).
12. [12] The National Institute for Health and Clinical Excellence, The Management of Hypertensive Disorders During Pregnancy. Clinical Guideline 107. 2010 August. (Accessed online on 20th June 2014 at http://www.nice.org.uk/nicemedia/live/13098/50418/50418.pdf).
13. [13] Henderson, J.T., Whitlock, E.P., O'Connor, E., Senger, C.A., Thompson, J.H., Rowland, M.G., Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 160:10 (2014), 695–703 May. (Pubmed PMID: 24711050).
14. [14] Akolekar, R., Syngelaki, A., Poon, L., Wright, D., Nicolaides, K.H., Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn. Ther. 33:1 (2013), 8–15 (Pubmed PMID: 22906914).
15. [15] Oliveira, N., Magder, L.S., Blitzer, M.G., Baschat, A.A., First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort. Ultrasound Obstet. Gynecol. 44:3 (2014), 279–285 (Pubmed PMID: 24913190).
16. [16] Park, F.J., Leung, C.H., Poon, L.C., Williams, P.F., Rothwell, S.J., Hyett, J.A., Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy. Aust. N Z J. Obstet. Gynaecol. 56:3 (2013), 532–539 (Pubmed PMID: 23919594).
17. [17] Nicolaides, K.H., UK Clinical Research Network. ASPRE (Version 1) Combined multi-marker screening and randomized patient treatment with aspirin for evidence based pre-eclampsia prevention., 2016 (URL: http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID=15680 Accessed 1st January 2016).
18. [18] American College of Obstetricians and Gynecologists, Hypertension in Pregnancy. 2013, American College of Obstetricians and Gynecologists, Washington, DC.
19. [19] Meads, C.A., Cnossen, J.S., Meher, S., Juarez-Garcia, A., ter Riet, G., Duley, L., et al. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modeling. Health Technol. Assess. 12:6 (2008), 1–270 Mar. (Pubmed PMID: 18331705).
20. [20] Chan, A.W., Tetzlaff, J.M., Altman, D.G., Laupacis, A., Gotzsche, P.C., Krleza-Jeric, K., et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann. Intern. Med. 158:3 (2013), 200–207 Feb 5. (PubMed PMID: 23295957).
21. [21] Rennis, D., CONSORT revised — improving the reporting of randomized trials. JAMA 285:15 (2001), 2006–2007 Apr. (Pubmed PMID: 11308440).
22. [22] Billingham, S.A.M., Whitehead, A.L., Julious, S.A., An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database. BMC Med. Res. Methodol., 13, 2013, 104 Aug. (Pubmed PMID: 23961782).
23. [23] Poon, L.C.Y., Zymery, N.A., Zamprakou, A., Syngelaki, A., Nicolaides, K.H., Protocol for measurement of mean arterial pressure at 11–13 weeks' gestation. Fetal Diagn Ther. 31:1 (2012), 42–48 (Pubmed PMID: 22248988).
24. [24] Bhide, A., Acharya, G., Bilardo, C.M., Brezinka, C., Cafici, D., Hernandez-Andrade, E., et al. ISUOG Practice guidelines: use of Doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol. 41:2 (2013), 233–239 Feb. (Pubmed PMID: 23371348).